These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 26331680)

  • 21. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.
    Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR
    Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein.
    Cohen JR; Lin LD; Machamer CE
    J Virol; 2011 Jun; 85(12):5794-803. PubMed ID: 21450821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.
    Netland J; DeDiego ML; Zhao J; Fett C; Álvarez E; Nieto-Torres JL; Enjuanes L; Perlman S
    Virology; 2010 Mar; 399(1):120-128. PubMed ID: 20110095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
    Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
    Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV proteins decrease levels and activity of human ENaC via activation of distinct PKC isoforms.
    Ji HL; Song W; Gao Z; Su XF; Nie HG; Jiang Y; Peng JB; He YX; Liao Y; Zhou YJ; Tousson A; Matalon S
    Am J Physiol Lung Cell Mol Physiol; 2009 Mar; 296(3):L372-83. PubMed ID: 19112100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between M protein and other structural proteins of severe, acute respiratory syndrome-associated coronavirus.
    Hsieh YC; Li HC; Chen SC; Lo SY
    J Biomed Sci; 2008 Nov; 15(6):707-17. PubMed ID: 18792806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis.
    Teoh KT; Siu YL; Chan WL; Schlüter MA; Liu CJ; Peiris JS; Bruzzone R; Margolis B; Nal B
    Mol Biol Cell; 2010 Nov; 21(22):3838-52. PubMed ID: 20861307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus.
    Ying W; Hao Y; Zhang Y; Peng W; Qin E; Cai Y; Wei K; Wang J; Chang G; Sun W; Dai S; Li X; Zhu Y; Li J; Wu S; Guo L; Dai J; Wang J; Wan P; Chen T; Du C; Li D; Wan J; Kuai X; Li W; Shi R; Wei H; Cao C; Yu M; Liu H; Dong F; Wang D; Zhang X; Qian X; Zhu Q; He F
    Proteomics; 2004 Feb; 4(2):492-504. PubMed ID: 14760722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus.
    Yu CJ; Chen YC; Hsiao CH; Kuo TC; Chang SC; Lu CY; Wei WC; Lee CH; Huang LM; Chang MF; Ho HN; Lee FJ
    FEBS Lett; 2004 May; 565(1-3):111-6. PubMed ID: 15135062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS coronavirus accessory proteins.
    Narayanan K; Huang C; Makino S
    Virus Res; 2008 Apr; 133(1):113-21. PubMed ID: 18045721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway.
    Keng CT; Akerström S; Leung CS; Poon LL; Peiris JS; Mirazimi A; Tan YJ
    Microbes Infect; 2011 Feb; 13(2):179-88. PubMed ID: 21035562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein.
    Tan YJ
    Virol J; 2005 Feb; 2():5. PubMed ID: 15703085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival.
    DeDiego ML; Nieto-Torres JL; Regla-Nava JA; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodriguez C; Perlman S; Enjuanes L
    J Virol; 2014 Jan; 88(2):913-24. PubMed ID: 24198408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.
    Simmons G; Reeves JD; Rennekamp AJ; Amberg SM; Piefer AJ; Bates P
    Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4240-5. PubMed ID: 15010527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A; Kashir J
    Med Hypotheses; 2020 Oct; 143():109906. PubMed ID: 32505910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic lesions within the 3a gene of SARS-CoV.
    Tan TH; Barkham T; Fielding BC; Chou CF; Shen S; Lim SG; Hong W; Tan YJ
    Virol J; 2005 Jun; 2():51. PubMed ID: 15963240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles.
    Siu YL; Teoh KT; Lo J; Chan CM; Kien F; Escriou N; Tsao SW; Nicholls JM; Altmeyer R; Peiris JS; Bruzzone R; Nal B
    J Virol; 2008 Nov; 82(22):11318-30. PubMed ID: 18753196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.